U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX1055547: GSM1708297: PTC17 - small RNAseq; Homo sapiens; miRNA-Seq
1 ILLUMINA (Illumina Genome Analyzer IIx) run: 6M spots, 239.1M bases, 149.6Mb downloads

Submitted by: Gene Expression Omnibus (GEO)
Study: The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells During Carcinogenesis
show Abstracthide Abstract
To comprehensively characterize microRNAs (miRNA) expression and their target genes in thyroid cancer, we performed next-generation sequencing expression analysis of this disease. Recent studies have found that only the most abundant microRNAs mediate significant target suppression. We sequenced small RNA from 8 papillary thyroid carcinomas (PTC) with paired samples of normal thyroid tissue. We found that only a small set of abundant miRNAs are differentially expressed after pair-wise comparison (12 upregulated and 8 downregulated) reaching the minimum threshold amount to repress target mRNAs. We integrated computational prediction of potential targets and mRNA sequencing from the paired normal and tumor thyroid tissues from the same eight patients with PTC. The integrated analyses identified a master microRNA regulatory network in PTC that is involved in essential biological processes such as thyroid differentiation. As both mature products of miR-146b (miR-146b-5p and -3p) were among the most abundant upregulated in tumors, we unveil their target genes and found that miR-146b-3p specifically binds to the 3`UTR of PAX8 and NIS, leading to an impaired translation of the proteins and subsequently decreasing the iodide uptake of the cells. Furthermore, we show that mir-146b and PAX8 regulate each other, describing a novel regulatory circuit that determines the differentiated phenotype of PTC. In conclusion, our integrative genomic analysis uncovers the target genes of two of the most upregulated miRNAs and highlights the importance of a miR-146b3p-PAX8-NIS regulatory circuit that determines thyroid differentiation in thyroid cancer. Overall design: Samples from Papillary Thyroid Carcinoma tumors (n=8) and contralateral normal thyroid tissue from the same patient (n=8) were collected at the Biobank of the Hospital Universitario La Paz (Madrid, Spain). The clinical characteristics of patients are summarized in Table S1. Surgically removed tissues were quickly frozen in liquid nitrogen until analysis. The samples were snap frozen on dry ice and stored at -80°C.
Sample: PTC17 - small RNAseq
SAMN03769216 • SRS958244 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina Genome Analyzer IIx
Strategy: miRNA-Seq
Source: TRANSCRIPTOMIC
Selection: size fractionation
Layout: SINGLE
Construction protocol: Surgically removed tissues were quickly frozen in liquid nitrogen until analysis. The samples were snap frozen on dry ice and stored at -80°C. Total RNA was extracted with TRIzol solution (Invitrogen), and the integrity of RNA was assessed using an Agilent BioAnalyzer 2100 (Agilent Technologies). All samples were collected with the informed consent of the patients and the experiments were approved by the Hospital Research Ethics Committee at Hospital Universitario La Paz. Illumina® TruSeq® Small RNA & Illumina® TruSeq® Stranded mRNA
Experiment attributes:
GEO Accession: GSM1708297
Links:
External link:
Runs: 1 run, 6M spots, 239.1M bases, 149.6Mb
Run# of Spots# of BasesSizePublished
SRR20594345,976,617239.1M149.6Mb2015-08-24

ID:
1532320

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...